Reviving the FDA: NEJM perspective

October 6, 2010

In a Perspective piece published online today in the New England Journal of Medicine, Georgetown University School of Medicine family medicine physician Susan Okie gives a comprehensive overview of change, and planned change, within the Food and Drug Administration (FDA). The review comes as the FDA's commissioner, Margaret Hamburg, completes her first year as the agency's leader.

Okie writes that the FDA's priorities over the past year have included "finding ways to make the FDA more nimble and proactive, restoring its and refocusing staff on its public health mission, persuading Congress to boost funding for its expanding portfolio of responsibilities, [and] sharpening its ability to deal with new science and globalization…"

To that end, Hamburg reportedly has spent hundreds of hours meeting with interest groups and meeting with key members of Congress to build alliances.

As Okie outlines, Hamburg and the deputy commissioner, Joshua Sharfstein, have already undertaken several changes at the agency. The two leaders have met with FDA employees to understand hurdles they encounter because of legal and regulatory requirements. Such discussions have prompted new measures to accelerate responses to urgent health threats. In nonemergency situations, changes that have been described as "nuanced" actions often achieve desired results, Sharfstein says.

Hamburg, Sharfstein and internal task forces have been "reexamining the processes for making decisions" about the safety and effectiveness of drugs and medical devices. Okie says the agency is awaiting reports next year by Institute of Medicine panels that are likely to recommend reforms. The leadership anticipates decisions that could lead to lasting changes at the agency.

Finally, Hamburg's longer-term priorities include regulatory science and globalization. The Commissioner tells Okie that in addition to advocating for increased funding, the agency hopes to collaborate with scientists in academia and industry, as well as other federal health agencies, on research and training in areas such as biomarker, bioimaging, clinical-trial analytics and pharmacoepidemiology.

As for , Okie reports that the agency is introducing a risk-based strategy for targeting priority inspections in order to "grapple with the expanding task of ensuring the safety of products… made overseas."

Hamburg says despite the criticism of her agency and the growing pains within "...overseas, the FDA is still considered the gold standard for a regulatory agency," while here at home she says, "I have encountered a sense of real eagerness... to support the FDA in its mission."

Explore further: Drug industry advocates join chorus to split FDA

Related Stories

Drug industry advocates join chorus to split FDA

March 22, 2009

(AP) -- As momentum builds to rework the nation's food-safety system after a salmonella outbreak linked to peanuts, the drug industry is hoping for a happy side effect: faster approvals for new medicines.

New FDA chiefs stress science, better food safety

May 26, 2009

(AP) -- The huge salmonella outbreak from peanut butter represented a failure of the Food and Drug Administration, that agency's new chiefs declared Tuesday - one they hope to fix.

FDA drug approvals mostly flat in 2009

January 5, 2010

(AP) -- Drug approvals from the Food and Drug Administration were flat last year compared with 2008 and warnings fell, even as the agency's new leadership struck a tougher stance on safety.

FDA Web site explains agency operations to public

January 12, 2010

(AP) -- The Food and Drug Administration is launching a new Web site explaining its operations to consumers as part of a broader effort to rebrand itself as a more accessible agency.

FDA stresses need to modernize its science

October 6, 2010

(AP) -- The Food and Drug Administration must update its scientific tools for reviewing prescription drugs, medical devices and tracking food safety, according to a list of priorities laid out Wednesday by agency leadership.

Recommended for you

How the finch changes its tune

August 3, 2015

Like top musicians, songbirds train from a young age to weed out errors and trim variability from their songs, ultimately becoming consistent and reliable performers. But as with human musicians, even the best are not machines. ...

Cow embryos reveal new type of chromosome chimera

May 27, 2016

I've often wondered what happens between the time an egg is fertilized and the time the ball of cells that it becomes nestles into the uterine lining. It's a period that we know very little about, a black box of developmental ...

Shaving time to test antidotes for nerve agents

February 29, 2016

Imagine you wanted to know how much energy it took to bike up a mountain, but couldn't finish the ride to the peak yourself. So, to get the total energy required, you and a team of friends strap energy meters to your bikes ...


Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Oct 16, 2010
"boost funding" appears multiple times in this article but when you give more money to an incompetent and corrupt agency you get more incompetence and corruption. The FDA stifles new cancer drug development, delay approvals driving up the costs to astronomical levels and with all of these delays what is the real cost in lives. The story of 19 year old Abigail Burroughs says it all here...http://www.abigai...tory.php
not rated yet Oct 16, 2010
this is the link I meant to post http://www.lef.or...s_01.htm

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.